Highly Cytotoxic Cu(II) Terpyridine Complexes as Chemotherapeutic Agents

Kaixin Ni,Nicolás Montesdeoca,Johannes Karges

DOI: https://doi.org/10.1039/d4dt00759j

IF: 4

2024-04-21

Dalton Transactions

Abstract:Cancer is considered as the biggest medicinal challenge worldwide. During a typical treatment, the tumorous tissue is removed in a surgical procedure and the patient further treated by chemotherapy. One of the most frequently applied drugs are platinum complexes. Despite their clinical success, these compounds are associated with severe side effects and low therapeutic efficiency. To overcome these limitations, herein, the synthesis and biological evaluation of Cu(II) terpyridine complexes as chemotherapeutic drug candidates is suggested. The compounds were found to be highly cytotoxic in the nanomolar range against various cancer cell lines. Mechanistic insights revealed that the compounds primarily accumulated in the cytoplasm and generated reactive oxygen species in this organelle, triggering cell death by apoptosis. Based on their high therapeutic effect, these metal complexes could serve as starting point for further drug development.

chemistry, inorganic & nuclear

What problem does this paper attempt to address?

The problem this paper attempts to address is the development of new, efficient anticancer drugs. Specifically, the researchers synthesized different methoxy-substituted copper(II) terpyridine complexes (Cu1-Cu3) and evaluated their cytotoxicity and potential anticancer mechanisms against various cancer cell lines. These copper(II) complexes exhibited high cytotoxicity at nanomolar concentrations and primarily induced apoptosis in cancer cells by accumulating in the cytoplasm and generating reactive oxygen species (ROS). Additionally, these compounds showed lower toxicity in normal cells, indicating good selectivity. The study aims to provide a promising starting point for subsequent drug development.